This demonstrated that CDK5 may phosphorylate AR via direct biochemical interaction in prostate cancer cells by manipulation of CDK5 with overexpression, knockdown, and drug-targeted inhibition [40]. This evidence concerns the gene AR and prostate carcinoma.